Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Objective Nutrients is a specialized nutraceutical company focused on the development and distribution of high-bioavailability nutritional supplements, particularly those targeting mitochondrial and metabolic health. The company's flagship product, Thiamax, utilizes Thiamine Tetrahydrofurfuryl Disulfide (TTFD), a disulfide derivative of Vitamin B1 known for its superior absorption and ability to cross the blood-brain barrier. Founded by nutritional therapist Elliot Overton, Objective Nutrients aims to provide solutions for thiamine deficiency and related conditions such as dysautonomia and chronic fatigue. The company emphasizes evidence-based formulations and provides educational resources to support the therapeutic use of high-dose thiamine. Their operations are primarily direct-to-consumer, serving a global market of health-conscious individuals and practitioners. In addition to thiamine, the company offers synergistic products like magnesium taurate to optimize nutrient utilization and metabolic pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Objective Nutrients.